Shanghai Bio-heart Biological Technology (2185.HK) Earnings Analysis
Shanghai Bio-heart Biological Technology (2185.HK) next reports earnings on 2026-07-31. Trailing P/E -7.15.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2185.HK next report earnings?
| Next earnings date | 2026-07-31 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
2185.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-12-31 | -0.27146 HKD | n/a | n/a | n/a |
2185.HK valuation and analyst view
| Trailing P/E | -7.15 |
|---|---|
| Trailing EPS | -0.29421 HKD |
| Price / book | 1.13 |
| Dividend yield | 0.00% |
| Market cap | 0.58B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shanghai Bio-heart Biological Technology (2185.HK)'s next earnings date?
Shanghai Bio-heart Biological Technology is next scheduled to report on 2026-07-31.
Did 2185.HK beat earnings last quarter?
Consensus estimate data was not available for 2185.HK's 2024-12-31 report.
What is 2185.HK's current P/E ratio and EPS?
2185.HK trades at a trailing P/E of -7.15 on trailing EPS of -0.2942089130462455 HKD.
What do analysts rate 2185.HK?
2185.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.